Education
About Us
Working with TipRanks
Follow Us
Provectus Pharmaceuticals (PVCT)
:PVCT
| Dec 23 | Dec 22 | Dec 21 | Dec 20 | Dec 19 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | $ 557.71K | $ 989.04K | $ 0.00 | $ 0.00 | $ 0.00 |
| Gross Profit | $ -1.14M | $ 925.26K | $ -94.12K | $ -315.37K | $ -756.36K |
| Operating Income | $ -2.90M | $ -3.43M | $ -4.67M | $ -4.96M | $ -6.30M |
| EBITDA | $ -2.89M | $ -3.36M | $ -4.52M | $ -4.64M | $ -5.48M |
| Net Income | $ -3.10M | $ -3.55M | $ -6.50M | $ -8.43M | $ -8.38M |
| Balance Sheet | |||||
| Cash & Short-Term Investments | $ 76.58K | $ 21.61K | $ 682.98K | $ 97.23K | $ 590.71K |
| Total Assets | $ 1.45M | $ 2.04M | $ 3.51M | $ 589.20K | $ 1.48M |
| Total Debt | $ 3.03M | $ 2.18M | $ 1.74M | $ 23.80M | $ 20.37M |
| Net Debt | $ 2.95M | $ 2.16M | $ 1.06M | $ 23.70M | $ 19.78M |
| Total Liabilities | $ 9.04M | $ 8.27M | $ 7.70M | $ 30.80M | $ 25.55M |
| Stockholders' Equity | $ -7.59M | $ -6.23M | $ -4.19M | $ -30.21M | $ -24.07M |
| Cash Flow | |||||
| Free Cash Flow | $ -2.57M | $ -3.04M | $ -1.01M | $ -4.09M | $ -6.19M |
| Operating Cash Flow | $ -2.57M | $ -3.04M | $ -1.01M | $ -4.09M | $ -6.19M |
| Investing Cash Flow | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 | $ 0.00 |
| Financing Cash Flow | $ 2.19M | $ 1.37M | $ 4.02M | $ 3.60M | $ 6.75M |